Novozymes A/S (NSIS-B.CO)

DKK 409.4

(-0.8%)

Annual Balance Sheets

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 28.39 Billion 27.98 Billion 24.76 Billion 20.51 Billion 20.43 Billion 19.69 Billion
Total Current Assets 9.46 Billion 9.24 Billion 7.82 Billion 6.91 Billion 7.05 Billion 6.83 Billion
Cash And Short Term Investments 1.15 Billion 1.12 Billion 1.03 Billion 1.3 Billion 711 Million 723 Million
Cash and Cash Equivalents 1.11 Billion 1.04 Billion 963 Million 1.18 Billion 711 Million 723 Million
Short Term Investments 40 Million 80 Million 75 Million 119 Million - -
Net Receivables 3.77 Billion 3.6 Billion 2.98 Billion 2.55 Billion 3.1 Billion 2.88 Billion
Inventory 3.62 Billion 3.8 Billion 2.99 Billion 2.36 Billion 2.61 Billion 2.82 Billion
Other Current Assets 947 Million 792 Million 880 Million 814 Million 619 Million 407 Million
Total Non-Current Assets 18.92 Billion 18.74 Billion 16.94 Billion 13.59 Billion 13.38 Billion 12.86 Billion
Net PPE 12.32 Billion 12.07 Billion 10.18 Billion 9.61 Billion 10.21 Billion 9.69 Billion
Good Will And Intangible Assets 4.53 Billion 4.69 Billion 5.02 Billion 2.55 Billion 1.92 Billion 2.13 Billion
Good Will 1.97 Billion 2 Billion 2.02 Billion 1.09 Billion 965 Million 1.08 Billion
Intangible Assets 2.55 Billion 2.69 Billion 3 Billion 1.45 Billion 961 Million 1.04 Billion
Long-Term Investments 205 Million 223 Million 29 Million 33 Million 59 Million 62 Million
Tax Assets 1.76 Billion 1.62 Billion 1.63 Billion 1.33 Billion - -
Other Non Current Assets 105 Million 124 Million 69 Million 61 Million 1.19 Billion 972 Million
Other Assets - - - - - -
Total Liabilities 14.04 Billion 13.75 Billion 12.56 Billion 9.26 Billion 8.95 Billion 8.25 Billion
Total Current Liabilities 7.26 Billion 6.96 Billion 5.67 Billion 4.16 Billion 4.73 Billion 5.52 Billion
Account Payables 1.61 Billion 1.86 Billion 1.49 Billion 1.1 Billion 1.11 Billion 1.41 Billion
Tax Payables 183 Million 326 Million 486 Million 336 Million - -
Short Term Debt 3.17 Billion 2.94 Billion 122 Million 136 Million 1.38 Billion 1.78 Billion
Deferred Revenue 2.4 Billion 1.99 Billion 2.01 Billion 970 Million 827 Million -
Other Current Liabilities 72 Million 158 Million 2.04 Billion 1.95 Billion 1.41 Billion 2.31 Billion
Total Non Current Liabilities 6.77 Billion 6.79 Billion 6.88 Billion 5.1 Billion 4.22 Billion 2.73 Billion
Long-Term Debt 4.56 Billion 3.9 Billion 360 Million 386 Million 3.15 Billion 1.46 Billion
Deferred Revenue Non Current 152 Million 129 Million 98 Million 3.36 Billion - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 101 Million 1.1 Billion 5.09 Billion 146 Million 1.06 Billion 1.26 Billion
Other Liabilities - - - - - -
Total Equity 14.35 Billion 14.22 Billion 12.2 Billion 11.24 Billion 11.48 Billion 11.43 Billion
Stock Holders Equity 13.97 Billion 13.83 Billion 11.82 Billion 11.23 Billion 11.46 Billion 11.42 Billion
Common Stock 562 Million 562 Million 564 Million 570 Million 582 Million 594 Million
Retained Earnings 13.75 Billion 13.06 Billion 11.3 Billion 11.26 Billion 10.81 Billion 10.94 Billion
Accumulated other comprehensive income -339 Million 213 Million -40 Million -600 Million 76 Million -112 Million
Common Stock Equity 13.97 Billion 13.83 Billion 11.82 Billion 11.23 Billion 11.46 Billion 11.42 Billion
Capital Lease Obligation 369 Million 411 Million 482 Million 522 Million 616 Million -
Total Investments 267 Million 315 Million 59 Million 54 Million 59 Million 62 Million
Total Debt 7.73 Billion 6.84 Billion 482 Million 522 Million 4.53 Billion 3.25 Billion
Net Debt 6.61 Billion 5.8 Billion -481 Million -659 Million 3.82 Billion 2.53 Billion

Balance Sheet Charts